findmyKOL

Kim Huffman, MD, PhD

Basic profile

Duke University

ORCID↗NPI↗
✓ Full record
RegionDurham, NC · SoutheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL type: EliteLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2008–2026Why? →

Kim Huffman is a Rheumatology/Immunology physician affiliated with Duke University. OpenAlex indexes 267 publications with 8,643 citations (h-index 47); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
267publications

Distinct works indexed by OpenAlex, matched via ORCID.

8,643citations

Total citations across indexed works.

47h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
3NIH grants · 2008–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5213 S Alston Ave
Durham, NC 277134430

Telephone

919-684-8111

Registry record last updated 5 Dec 2012.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    46.9%
    Folate Analog Metabolic Inhibitor46.9%
    Methotrexate100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    30.6%
    Corticosteroid30.6%
    Prednisone100%
    Part D<11 patients
  • Musculoskeletal

    22.4%
    Nonsteroidal Anti-inflammatory Drug22.4%
    Diclofenac Sodium100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”